Head and Neck Squamous Cell Carcinoma (HNSCC) Completed Phase 2 Trials for DB06626 (Axitinib)

Also known as: Head and Neck Squamous Cell Carcinoma

IndicationStatusPhase
DBCOND0043665 (Head and Neck Squamous Cell Carcinoma (HNSCC))Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01469546Phase II Trial Evaluating Axitinib In Patients With Unresectable, Recurrent Or Metastatic Head And Neck CancerTreatment